Reduced number of CD1a+ cells in cutaneous B-cell lymphoma

American Journal of Clinical Pathology

Volumn 116, Issue 1, 2001, Pages 72-78

  Schmuth, M ^a   Sidoroff, A ^a   Danner, B ^a   Topar, G ^a   Sepp, N T ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antigen presenting cells; CD1a; Cutaneous lymphoma; Immunohistochemistry

Indexed keywords

CD1 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CHILD; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOLYMPHOMA; SKIN LYMPHOMA; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; CELL COUNT; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PSEUDOLYMPHOMA; SKIN NEOPLASMS;

EID: 0034955894     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/G828-D7YC-Y98R-QRR9     Document Type: Article

References (48)

1. EORTC classification for primary cutaneous lymphomas: A comparison with the REAL Classification and the proposed WHO Classification
2. Cutaneous lymphomas: A proposal for a unified approach to classification using the REAL/WHO classification
3. Cutaneous pseudolymphomas
4. Cutaneous lymphoid hyperplasias
5. Inflammatory diseases that simulate lymphomas cutaneous pseudolymphomas
6. Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas: A comparative clinicopathologic study of 57 patients
7. Multiple cutaneous B-cell pseudolymphomas after allergen injections
8. Lymphadenosis benigna cutis resulting from Borrelia infection (Borrelia lymphocytoma)
9. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma
10. Cutaneous pseudolymphoma vs cutaneous malignant lymphoma criteria for histologic differentiation
11. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: A study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin
12. Immunohistochemical classification of cutaneous pseudolymphomas: Delineation of distinct patterns
13. Architectural and antigenic features of follicular dendritic cells as a clue to the histogenesis of primary cutaneous B-cell lymphoma
14. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation
15. Use of monoclonal antibodies (UCHL1, Ki-B3) against T and B cell antigens in routine paraffin-embedded skin biopsy specimens
16. Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: A comparative study
17. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: Differential diagnostic and pathogenetic aspects
18. Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells: A clinicopathologic study of 18 patients
19. Apoptotic index: Discriminant feature for the differentiation of cutaneous diffuse malignant follicular center cell lymphomas from lymphoid hyperplasia
20. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases
21. Diagnostic immunohistology: Cutaneous lymphomas and pseudolymphomas
22. Structure and function of the CD1 family of MHC-like cell surface proteins
23. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells
24. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders
25. Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis
26. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema
27. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption
28. Ultraviolet light depletes surface markers of Langerhans cells
29. Dendritic cells in T- and B-cell proliferation in the skin
30. Demonstration of OKT 6-reactive cells in mycosis fungoides
31. Cutaneous lymphoid hyperplasia: Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma
32. Immunohistochemical studies in lymphocytic infiltration of the skin (Jessner) and discoid lupus erythematosus: A comparative study
33. Cutaneous expression of Thy-1 in mycosis fungoides
34. Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer
35. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours
36. Differentiation of primary and secondary cutaneous B-cell lymphoma by Southern blot analysis
37. Circuits and signals of the skin-associated lymphoid tissues (SALT)
38. MALT and SALT: The clue to cutaneous B-cell lymphoproliferative disease
39. Lymphomatoid papulosis followed by large-cell lymphoma: Immunophenotypical and genotypical analysis
40. Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy
41. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia
42. Immunologic functions of Ia-bearing epidermal Langerhans cells
43. Dendritic cells: From ignored cells to major players in T-cell-mediated immunity
44. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis
45. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: Involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells
46. Langerhans cells: Involvement in the pathogenesis of mycosis fungoides
47. Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells
48. Significance of non-lymphoid ("accessory") cells in malignant lymphomas and pseudolymphomas of the skin